• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

lifescan

Study supports smart blood glucose meter from LifeScan

May 18, 2023 By Sean Whooley

LifeScan OneTouch app

LifeScan today announced positive data from a study of real-world evidence supporting its Bluetooth-connected blood glucose meter. Evidence from more than 55,000 people with diabetes demonstrated sustained improvements in readings in range. The analysis focuses on changes over 180 days. LifeScan published results in the peer-reviewed journal Diabetes Therapy. The company’s OneTouch Bluetooth-connected blood glucose […]

Filed Under: Clinical Trials, Diabetes, Featured, Patient Monitoring, Technology Tagged With: lifescan

LifeScan launches digital diabetes management platform

October 25, 2021 By Sean Whooley

LifeScan OneTouch app

LifeScan announced today that it launched its OneTouch solutions offering wellness programs to help people manage their diabetes. Malvern, Pennsylvania-based LifeScan made its OneTouch solutions available to consumers in the U.S. now and plans to soon offer it to healthcare providers, payors and employers as a reimbursed adjudicated option in early 2022. OneTouch solutions connects […]

Filed Under: Big Data, Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: lifescan

LifeScan inks deal to broker institutional sales for OneTouch Reveal Plus

October 2, 2019 By Sean Whooley

LifeScan OneTouch app

LifeScan said yesterday that it entered into an agreement with Willis Towers Watson to expand the commercialization of its OneTouch Reveal Plus digital diabetes therapy system. The companies hope the collaboration will see LifeScan and Willis Towers Watson combine to support self-insured employers in helping their employees and dependents manage diabetes. The OneTouch Reveal Plus […]

Filed Under: Diabetes, Featured, Mergers & Acquisitions, Patient Monitoring Tagged With: lifescan, welldoc

LifeScan releases latest version of diabetes management app

October 30, 2018 By Sarah Faulkner

LifeScan OneTouch app

LifeScan said today that it released the latest version of its OneTouch Reveal mobile app. The digital tool is designed to help people with diabetes track their blood sugar levels using their mobile devices and share data with healthcare teams and caregivers. The newest version of LifeScan’s app includes notifications that automatically warn users of […]

Filed Under: Diabetes, Featured, Patient Monitoring, Wall Street Beat Tagged With: lifescan

Johnson & Johnson OKs $2B LifeScan sale to Platinum Equity

June 12, 2018 By Brad Perriello

Johnson & Johnson

Johnson & Johnson (NYSE:JNJ) said today that it accepted a binding offer of more than $2 billion from private equity shop Platinum Equity for its LifeScan blood glucose monitoring business as it moves toward the exit in the diabetes market. The New Brunswick, N.J.-based healthcare conglomerate early last year announced a strategic review of its LifeScan, […]

Filed Under: Diabetes, Featured, Mergers & Acquisitions, Wall Street Beat Tagged With: johnsonandjohnson, lifescan

Johnson & Johnson moves closer to exiting the diabetes business with $2.1B LifeScan sale

March 16, 2018 By Brad Perriello

Johnson & Johnson

Johnson & Johnson (NYSE:JNJ) took another step toward the exit door for the diabetes business, agreeing to a $2,1 billion offer from private equity shop Platinum Equity for its LifeScan blood glucose monitoring unit. The New Brunswick, N.J.-based healthcare conglomerate early last year announced a strategic review of its LifeScan, Animas and Calibra Medical diabetes businesses and later […]

Filed Under: Diabetes, Featured, Mergers & Acquisitions, Wall Street Beat Tagged With: johnsonandjohnson, lifescan

J&J’s LifeScan touts studies of OneTouch blood glucose monitoring system

October 24, 2017 By Sarah Faulkner

Johnson & Johnson

Two recently-published studies of LifeScan‘s OneTouch Verio Flex blood glucose monitoring system showed that the technology is accurate, reliable and linked with improvements in glycemic control, the Johnson & Johnson (NYSE:JNJ) business touted today. The release comes just days after the healthcare giant revealed that it plans to shut down its Animas insulin pump business and review […]

Filed Under: Diabetes, Featured, Patient Monitoring, Pharmaceuticals, Wall Street Beat Tagged With: johnsonandjohnson, lifescan

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS